Kala Pharmaceuticals

by in

Entry	Author	Date	Location
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist	Bernadette Tansey	03/01/13	Boston
Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round	VentureDeal	03/01/13	Boston
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs	Luke Timmerman	02/28/13	Boston
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News	Erin Kutz	07/13/12	Boston
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug	Erin Kutz	03/23/12	Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases	Arlene Weintraub	03/19/12	Boston
In Boston Life Sciences News: Akili, Kala, And Genocea	Erin Kutz	03/16/12	Boston
Kala Pharmaceuticals Lands $6,200,000 Seed Round	VentureDeal	03/14/12	Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra	Gregory T. Huang	04/19/11	Boston
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News	Rebecca Zacks	11/18/10	Boston
$3M for Kala Pharmaceuticals	Ryan McBride	11/12/10	Boston
Kala Pharmaceuticals Garners $3,000,000 New Financing Round	VentureDeal	11/10/10	Boston
The Boston Deals You Missed During the Holidays: Cash for Kala Pharma, Funds for ViewFinity, Silver for SCVNGR, & More	Ryan McBride	01/04/10	Boston
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M	Luke Timmerman	12/23/09	Boston
Page 1 of 1

Xconomy National